Gamal Y S Raia, Eman Abdelsameea, Dalia Hamdy Twfic Taie, Omar Elshaarawy, Noha Rabie Bayomy, Rasha G Mostafa, Aml Abd Alhamid Alsharnoby, Karema Abdelhady Diab
{"title":"TM6SF2变异体作为慢性肝病患者肝细胞癌发展的危险因素","authors":"Gamal Y S Raia, Eman Abdelsameea, Dalia Hamdy Twfic Taie, Omar Elshaarawy, Noha Rabie Bayomy, Rasha G Mostafa, Aml Abd Alhamid Alsharnoby, Karema Abdelhady Diab","doi":"10.5114/ceh.2022.119265","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Hepatocellular carcinoma (HCC) is one of the most prevalent cancers worldwide. A non-synonymous single nucleotide polymorphism (SNP) of the transmembrane 6 superfamily member 2 (<i>TM6SF2</i>) gene is associated with non-alcoholic fatty liver disease. SNPs of the <i>TM6SF2</i> gene play an important role in the pathogenesis of HCC in alcoholic cirrhosis, but there are limited data regarding other possible etiologies. We aimed to evaluate the role of the rs58542926 polymorphism in the development of HCC in Egyptian chronic liver disease (CLD) patients.</p><p><strong>Material and methods: </strong>A total of 120 participants, including 40 HCC patients, 40 CLD patients, and 40 healthy controls, were selected. Real-time polymerase chain reaction (RT-PCR) was used to detect the <i>TM6SF2</i> rs58542926 polymorphism.</p><p><strong>Results: </strong>There were no significant differences among the three studied groups regarding age (<i>p</i> = 0.06) and gender (<i>p</i> = 0.75). Frequencies of the CT, TT, CT + TT genotypes and the T allele were significantly higher in HCC patients than in the CLD and control groups (<i>p</i> < 0.001, <i>p</i> = 0.005, and <i>p</i> < 0.001, respectively). CLD patients with the CT genotype had a significantly increased risk of HCC development (OR = 4.67, 95% CI: 1.67-12.90). Patients with the TT genotype had a significantly increased risk of HCC (OR = 9.33, 95% CI: 1.72-50.61). Moreover, the T allele was correlated with an increased risk of HCC (OR = 5.44, 95% CI: 2.09-14.17) compared to the C allele.</p><p><strong>Conclusions: </strong>The <i>TM6SF2</i> rs58542926 genotype is associated with an increased risk of HCC in the Egyptian population.</p>","PeriodicalId":10281,"journal":{"name":"Clinical and Experimental Hepatology","volume":"8 3","pages":"211-218"},"PeriodicalIF":1.5000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6d/37/CEH-8-47759.PMC9850315.pdf","citationCount":"0","resultStr":"{\"title\":\"The TM6SF2 variant as a risk factor for hepatocellular carcinoma development in chronic liver disease patients.\",\"authors\":\"Gamal Y S Raia, Eman Abdelsameea, Dalia Hamdy Twfic Taie, Omar Elshaarawy, Noha Rabie Bayomy, Rasha G Mostafa, Aml Abd Alhamid Alsharnoby, Karema Abdelhady Diab\",\"doi\":\"10.5114/ceh.2022.119265\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Hepatocellular carcinoma (HCC) is one of the most prevalent cancers worldwide. A non-synonymous single nucleotide polymorphism (SNP) of the transmembrane 6 superfamily member 2 (<i>TM6SF2</i>) gene is associated with non-alcoholic fatty liver disease. SNPs of the <i>TM6SF2</i> gene play an important role in the pathogenesis of HCC in alcoholic cirrhosis, but there are limited data regarding other possible etiologies. We aimed to evaluate the role of the rs58542926 polymorphism in the development of HCC in Egyptian chronic liver disease (CLD) patients.</p><p><strong>Material and methods: </strong>A total of 120 participants, including 40 HCC patients, 40 CLD patients, and 40 healthy controls, were selected. Real-time polymerase chain reaction (RT-PCR) was used to detect the <i>TM6SF2</i> rs58542926 polymorphism.</p><p><strong>Results: </strong>There were no significant differences among the three studied groups regarding age (<i>p</i> = 0.06) and gender (<i>p</i> = 0.75). Frequencies of the CT, TT, CT + TT genotypes and the T allele were significantly higher in HCC patients than in the CLD and control groups (<i>p</i> < 0.001, <i>p</i> = 0.005, and <i>p</i> < 0.001, respectively). CLD patients with the CT genotype had a significantly increased risk of HCC development (OR = 4.67, 95% CI: 1.67-12.90). Patients with the TT genotype had a significantly increased risk of HCC (OR = 9.33, 95% CI: 1.72-50.61). Moreover, the T allele was correlated with an increased risk of HCC (OR = 5.44, 95% CI: 2.09-14.17) compared to the C allele.</p><p><strong>Conclusions: </strong>The <i>TM6SF2</i> rs58542926 genotype is associated with an increased risk of HCC in the Egyptian population.</p>\",\"PeriodicalId\":10281,\"journal\":{\"name\":\"Clinical and Experimental Hepatology\",\"volume\":\"8 3\",\"pages\":\"211-218\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2022-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6d/37/CEH-8-47759.PMC9850315.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Experimental Hepatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5114/ceh.2022.119265\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/ceh.2022.119265","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
The TM6SF2 variant as a risk factor for hepatocellular carcinoma development in chronic liver disease patients.
Introduction: Hepatocellular carcinoma (HCC) is one of the most prevalent cancers worldwide. A non-synonymous single nucleotide polymorphism (SNP) of the transmembrane 6 superfamily member 2 (TM6SF2) gene is associated with non-alcoholic fatty liver disease. SNPs of the TM6SF2 gene play an important role in the pathogenesis of HCC in alcoholic cirrhosis, but there are limited data regarding other possible etiologies. We aimed to evaluate the role of the rs58542926 polymorphism in the development of HCC in Egyptian chronic liver disease (CLD) patients.
Material and methods: A total of 120 participants, including 40 HCC patients, 40 CLD patients, and 40 healthy controls, were selected. Real-time polymerase chain reaction (RT-PCR) was used to detect the TM6SF2 rs58542926 polymorphism.
Results: There were no significant differences among the three studied groups regarding age (p = 0.06) and gender (p = 0.75). Frequencies of the CT, TT, CT + TT genotypes and the T allele were significantly higher in HCC patients than in the CLD and control groups (p < 0.001, p = 0.005, and p < 0.001, respectively). CLD patients with the CT genotype had a significantly increased risk of HCC development (OR = 4.67, 95% CI: 1.67-12.90). Patients with the TT genotype had a significantly increased risk of HCC (OR = 9.33, 95% CI: 1.72-50.61). Moreover, the T allele was correlated with an increased risk of HCC (OR = 5.44, 95% CI: 2.09-14.17) compared to the C allele.
Conclusions: The TM6SF2 rs58542926 genotype is associated with an increased risk of HCC in the Egyptian population.
期刊介绍：
Clinical and Experimental Hepatology – quarterly of the Polish Association for Study of Liver – is a scientific and educational, peer-reviewed journal publishing original and review papers describing clinical and basic investigations in the field of hepatology.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
